Celltrion biosimilars gain share in Australia and New Zealand
Celltrion's anticancer drugs and autoimmune disease products are gaining market share in Australia and New Zealand, according to market data, reflecting broader uptake of biosimilars in the region. According to IQVIA, as of the third quarter of 2025 …